← FDA DRUG APPROVALS

FDA ANDA · ANDA089098

HYDRALAZINE HYDROCHLORIDE

Sponsor: PLIVA

APPLICATION
ANDA089098
TYPE
ANDA
ORIGINAL APPROVAL
1985-12-18
LATEST ACTION
2014-09-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

HYDRALAZINE HYDROCHLORIDEPrescription
HYDRALAZINE HYDROCHLORIDE 100MG · TABLET · ORAL

Approval history

2014-09-11Manufacturing (CMC) · Supplement 32AP
2013-01-29Labeling · Supplement 33 · standardAP
2010-11-01Labeling · Supplement 23AP
2001-10-11Labeling · Supplement 8AP
2001-06-15Manufacturing (CMC) · Supplement 6AP
2001-05-29Manufacturing (CMC) · Supplement 7AP
2000-07-07Manufacturing (CMC) · Supplement 5AP
1994-05-11Manufacturing (CMC) · Supplement 4AP
1987-04-23Manufacturing (CMC) · Supplement 1AP
1985-12-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →